GBM (IMAGE)

University of Pennsylvania School of Medicine

GBM

Caption

A blood test that measures the amount of cell-free DNA (cfDNA) in the bloodstream -- called a liquid biopsy -- correlates with how patients will progress after they are diagnosed with glioblastoma.

Credit

Penn Medicine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.